Literature DB >> 11084820

Transanal endoscopic surgery for rectal tumors.

D Arribas del Amo1, J M Ramírez Rodríguez, V Aguilella Diago, M Elía Guedea, M J Palacios Fanlo, M Martínez Díez.   

Abstract

OBJECTIVE: To report our results with local excision by transanal endoscopic microsurgery (TEM) to treat 42 cases of rectal lesions (29 adenomas and 13 carcinomas).
METHODS: Prospective, descriptive study. Sex distribution: 55% men, 45% women, mean age 65 years (range: 17-84 years). SYMPTOMS: rectal bleeding 67%, diarrhea 23%. SURGICAL TECHNIQUE: mucosectomy 6 cases, full-thickness excision 36 cases. Average follow-up: 11 months (range: 1-36 months).
RESULTS: We analyzed operating time (average 85 min; range: 25-180 min), bleeding (average 100 ml, range 10-350 ml), distance of the tumor from the anal verge (lower tumor margin: mean, 8.8 cm; range, 1-20 cm; distal tumor margin: mean, 12.9 cm; range, 5-22 cm), tumor size (mean, 3.9 cm; range, 2-10 cm), postoperative hospital stay (average, 4 days; range, 2-15 days), morbidity (hemorrhage 1 case; perforation, 1 case), mortality (0) and follow-up (temporary incontinence to flatus in 6 cases, 1 recurrence of carcinoma treated with abdominoperineal resection, 2 recurrences of adenoma and 2 new adenomas).
CONCLUSIONS: TEM is a safe technique for the treatment of rectal lesions. Low morbidity and recurrence rates and short hospital stays make TEM a procedure of choice when local rectal surgery is indicated.

Entities:  

Mesh:

Year:  2000        PMID: 11084820

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  2 in total

1.  Anorectal functional results after transanal endoscopic microsurgery in benign and early malignant tumors.

Authors:  Zhiming Jin; Lu Yin; Lijun Xue; Moubin Lin; Qi Zheng
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

2.  Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.

Authors:  Maria A Gascon; Vicente Aguilella; Tomas Martinez; Luigi Antinolfi; Javier Valencia; Jose M Ramírez
Journal:  Langenbecks Arch Surg       Date:  2022-06-22       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.